Retina

With imaging artifacts common, clinicians must be focused on key points

Technology makes great tool, requires extra vigilance with co-existing disease

Quick visual recovery is important for this young population

Physicians also can focus on treating inflammation and IOP in patients

The MDA is a nonprofit health organization dedicated to educating and empowering patients with AMD.

Despite advances, imaging can only be complementary to clinician’s assessment

Educational format providing pipeline of information about complicated disease By

Here's the latest innovations at Neurotech Pharmaceuticals, Inc. 

Surgeon offers some cautionary tales about unfortunate cases he has encountered

Study: AI can detect swelling, severity of that swelling in macula of patients with diabetes

Check out the latest from the Medical News Minute

Letters to the Editor may be submitted to [email protected]. Letters may be edited for clarity and length.

Ophthalmology benefiting from active programs for innovative product development in 2018 and onward

Novel transparent, head-wearable camera display aims to make ophthalmic surgery more precise

Ragui Sedeek, MD, shares four pearls on how you can discuss diabetic treatments with your patients.

Diabetic eye disease is occurring in younger populations, which means it's time to rethink anti-VEGF standards.

In the first part of his Clinical Innovation series, Josh Mali, MD, shares how this novel home-use device is the new standard of care for AMD monitoring. Future blogs in the series will discuss the increased efficacy of patient monitoring and present case examples.

The 2017 meeting of the American Academy of Ophthalmology will convene in New Orleans from Nov. 11 to 14. Go to www.aao.org/annual meeting for the latest updates

How do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding? A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.

When dealing with patients with retinal disease, macular disease, or a meaningful risk of retinal detachment, certain types of IOLs should be avoided due to potential complications.

Intravitreal injections and posterior capsule rupture during cataract surgery: is there a risk? Research published in the American Journal of Ophthalmology may have an answer.